NQO1 and cancer: Previous NSCLC NQO1 studies utilized mixed subtype cohorts and performed IHC and immunofluorescence with single antibodies targets, demonstrating differences in antioxidant function and prognostic outcome, which is dependent on the cancer stage [22,29].